Endocrinologists are biting into radiology’s control over the management of nuclear imaging procedures involving an administration of radioiodine.
Endocrinologists are biting into radiology’s control over the management of nuclear imaging procedures involving an administration of radioiodine.
An analysis of Medicare patient procedural data by Dr. Charles .M. Intenzo, a nuclear physician at Thomas Jefferson University in Philadelphia found that radiology’s share of procedures involving the administration of radioiodine dropped 7% from 1996 to 2007. At the same time, the number of procedures administered by endocrinologists jumped by nearly one-third (32%).
The total number of such procedures covered by Medicare Part B remained stable over the 10-year period. Medicare covered 13,273 procedures requiring radioiodine in 1996. The total in 2007 was 13,004.
Endocrinology practice revolves around a limited number of applications, so practitioners are naturally attracted to these procedures as a new source of income. Regulatory barriers to their involvement have fallen as the Department of Energy has watered down the minimum training requirements for isotope handling and administration, Intenzo said.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
What Emerging CT Research Reveals About Obesity and Post-Op Survival for Non-Small Cell Lung Cancer
January 29th 2025For those without low skeletal muscle mass on CT and myosteatosis, obese patients have a 23 percent lower risk of death than non-obese patients after undergoing curative resection for non-small cell lung cancer, according to newly published research.